NCT01365260View on ClinicalTrials.gov

Safety and Efficacy of an Injectable Medical Device to Treat Knee Osteoarthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Knee Osteoarthritis
Interventions
DEVICE

MM-II

Single intraarticular (knee) injection of MM-II

DEVICE

DurolaneTM

Single intraarticular (knee) injection of DurolaneTM

Trial Locations (1)

91120

Hadassah Mount Scopus Hospital, Jerusalem

Sponsors
All Listed Sponsors
lead

Moebius Medical Ltd.

INDUSTRY

NCT01365260 - Safety and Efficacy of an Injectable Medical Device to Treat Knee Osteoarthritis | Biotech Hunter | Biotech Hunter